Delivery Order SPE2DB22D3010-SPE2DB25FP1LB
Award Date
1/22/25
Potential Completion Date
2/12/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order is for the supply of ORGOVYX 120 MG TABLET medical products. The contract has an ultimate completion date of March 12, 2025 and was awarded on February 19, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTHF4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order is for the supply of 4567583610 ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of April 4, 2025 and was awarded on March 14, 2025. This award is not associated with a set-aside...
This federal contract award SPE2DB24D3015|SPE2DB25FFXDE, valued at $1,375.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORGOVYX 120 MG TABLET UU 30S, a medical product, with a completion date of December 18, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, identified as SPE2DB24D2018|SPE2DB25FWSS2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,385.52, is a delivery order for the supply of ORGOVYX 120 MG TABLET UU 30S. The contract has an ultimate completion date of February 20, 2025 and was awarded on January 29, 2025. It is a Firm Fixed Price contract with no set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 Firm Fixed Price Delivery Order is for the supply of ORGOVYX 120 MG TABLET, a pharmaceutical product, with a period of performance through January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, with the ID SPE2DB22D3010|SPE2DB25FP1JT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $1,375.85 and is a Firm Fixed Price Delivery Order contract running through February 5, 2025. The contract covers the procurement of the pharmaceutical product ORGOVYX 120 MG Tablet, which is used in the treatment of various medical conditions....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,751.72 firm fixed-price delivery order is for the pharmaceutical product ORGOVYX 120 MG TABLET UU 30S, with a completion date of December 12, 2024. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 firm fixed-price delivery order is for the supply of ORGOVYX 120 MG TABLET medication. The contract has an ultimate completion date of December 11, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award, identified as SPE2DB22D2206 and SPE2DB25FDU71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,979.34, is for the delivery of ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,771.04 firm fixed-price delivery order contract is for the supply of ORGOVYX 120 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 18, 2025 and was awarded on January 27, 2025. This contract is part of a larger $999,999,999...